Investment
Crescendas has investments in companies with emerging technologies that aim to conserve resources and protect the environment, as well as in semi-conductor and biomedical applications.
Crescendas invests in companies with emerging technologies focused on resource conservation, environmental protection, semiconductors, and biomedical applications. We add value through business and market development and financial support. Our strategy prioritizes companies with growth potential, deep tech and green technology, innovative IP-protected technology, and strong management.
One key investment is in EnGeneIC, a biopharmaceutical company developing targeted cancer therapy nanocells. Crescendas supports EnGeneIC’s clinical trials and FDA approval efforts, enhancing our presence in Asia through strategic partnerships with the Singapore Institute of Advanced Medicine Holdings and Singapore Medical Incorporation.